Enhanced immunogenicity of recombinant hepatitis B vaccine in exposed family contacts of chronic liver disease patients

Scandinavian Journal of Infectious Diseases

Volumn 33, Issue 8, 2001, Pages 618-621

  Thakur, V ^a   Guptan, R C ^a   Basir, S F ^a   Parvez, M K ^a   Sarin, S K ^a  

^a G B PANT HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN G; RECOMBINANT HEPATITIS B VACCINE; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; EXPOSURE; FAMILY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; PROTECTION; VACCINATION;

ADOLESCENT; ADULT; DNA, VIRAL; ENVIRONMENTAL EXPOSURE; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VACCINES, SYNTHETIC;

EID: 0034893048     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540110026683     Document Type: Article

References (20)

1. Hepatitis B virus infection among household contacts of patients with acute HBsAg positive hepatitis
2. Necessity to vaccinate spouses of hepatitis B patients and carriers
3. Vertical transmission of hepatitis B antigen in Taiwan
4. Horizontal transmission of hepatitis B virus infection in household contacts in Pune, India
5. Prevention of primary liver cancer by immunization
6. A controlled clinical trial of the efficacy of hepatitis B vaccine (Hepavax B). A final report
7. Hepatitis B vaccination. What are the current international recommendations
8. Hepatitis B vaccine immune responses in children from families with an HBsAg carrier
9. Clinical trials of hepatitis B vaccine in the families of HBV carriers
10. Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: Implication in hepatitis B vaccination programs
11. Significance of isolated antibody to hepatitis B core antigen, determined by immune response to hepatitis B vaccination
12. Hepatitis B vaccination alone is not adequate for the categorizing of adult subjects with isolated anti-HBc
13. Hepatitis B vaccination of relatives of hepatitis B virus DNA positive carriers: An experience with plasma derived vaccine
14. Hepatitis B in high risk groups in India
15. Prevalence of hepatitis B infection and disease in contacts of chronic liver disease patients: Analysis of HBeAg positive versus HBeAg negative patients
16. Frequency and clinical profile of precore and surface hepatitis B mutants in Asian Indians with chronic liver disease
17. Clinical spectrum of hepatitis B in India
18. Significance of isolated antibody to hepatitis B core antigen determined by immune response to hepatitis B vaccination
19. Five year follow up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine vs. plasma derived vaccine in children: Immunogenicity and anamnestic responses
20. Specific vaccine therapy in chronic hepatitis B infection